CVS Health Corp
F:CVS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
42.48
72.73
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
CVS
stock under the Base Case scenario is
137.45
EUR.
Compared to the current market price of 66.9 EUR,
CVS Health Corp
is
Undervalued by 51%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for CVS Health Corp.
| US |
C
|
Cigna Group
XMUN:CGN
|
|
| US |
|
Cigna Corp
NYSE:CI
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
CVS’s pivot into full-scale healthcare services, including the integration of Aetna and recent acquisitions like Signify Health, is stretching the company’s resources and may strain operational efficiency if the synergy benefits take too long to materialize.
Heavier regulatory scrutiny around pharmacy benefit managers (PBMs) poses a direct threat to CVS’s industry-leading Caremark, potentially constraining profit margins and prompting costly compliance measures that could neutralize growth.
With competition from both traditional retailers expanding their pharmacy segments and digital-first disruptors targeting medication delivery and telehealth, CVS risks losing market share if it cannot keep pace with evolving consumer preferences for convenience and online access.
CVS’s vertically integrated business model—combining retail pharmacy, PBM services, and health insurance under one roof—creates potential for strong cross-selling and cost-saving synergies unmatched by many peers in the healthcare industry.
The company’s HealthHUB strategy transforms select stores into focused healthcare destinations, letting CVS capture higher-margin clinical services revenue and differentiate itself from purely transactional pharmacy competitors.
Strong cash flows from its core retail and PBM segments enable CVS to invest heavily in digital health initiatives and more strategic acquisitions, positioning it to deliver diversified revenue growth over the long term.
Revenue & Expenses Breakdown
CVS Health Corp
Balance Sheet Decomposition
CVS Health Corp
| Current Assets | 77.1B |
| Cash & Short-Term Investments | 11.2B |
| Receivables | 43.9B |
| Other Current Assets | 22B |
| Non-Current Assets | 178.2B |
| Long-Term Investments | 31.6B |
| PP&E | 28.1B |
| Intangibles | 111.5B |
| Other Non-Current Assets | 7.1B |
| Current Liabilities | 92.7B |
| Accounts Payable | 60.9B |
| Accrued Liabilities | 25.3B |
| Short-Term Debt | 1.2B |
| Other Current Liabilities | 5.2B |
| Non-Current Liabilities | 89.7B |
| Long-Term Debt | 60.5B |
| Other Non-Current Liabilities | 29.2B |
Free Cash Flow Analysis
CVS Health Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
CVS Health Corp
|
Revenue
|
394.1B
USD
|
|
Cost of Revenue
|
-339.4B
USD
|
|
Gross Profit
|
54.7B
USD
|
|
Operating Expenses
|
-43.9B
USD
|
|
Operating Income
|
10.8B
USD
|
|
Other Expenses
|
-10.3B
USD
|
|
Net Income
|
469m
USD
|
CVS Profitability Score
Profitability Due Diligence
CVS Health Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
CVS Health Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
CVS Solvency Score
Solvency Due Diligence
CVS Health Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
CVS Health Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CVS Price Targets Summary
CVS Health Corp
According to Wall Street analysts, the average 1-year price target for
CVS
is 80.7 EUR
with a low forecast of 67.87 EUR and a high forecast of 93.46 EUR.
Dividends
Current shareholder yield for
CVS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CVS
stock under the Base Case scenario is
137.45
EUR.
Compared to the current market price of 66.9 EUR,
CVS Health Corp
is
Undervalued by 51%.